ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.

FindCenter AddIcon
FindCenter Post-Image

The Interview: MDMA-Therapy Expert Dr. Rick Doblin

The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression